News Sentiment

AARD sentiment intelligence

Aardvark Therapeutics, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 47 Balanced news tone 61 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 7.60 Week of 10 Jul 2026
Weighted tone 47/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+33.3% over one week, +94.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Aardvark Therapeutics(AARD) Stock Options Chain | Quotes & News

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 33.3% Price confirming higher
Trend fit Trend inactive 94.9% over four weeks
Fair value -22.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 38
Negative 13

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
Market source 8
simplywall.st 5
Stocktwits 4
Stock Titan 4
www.marketscreener.com 4
TradingKey 3
MT Newswires 3

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 17
Analyst action 6
Regulatory and legal 4
Capital return 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 61